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Bacterial surfaces are decorated with distinct carbohydrate structures that may
substantially differ among species and strains. These structures can be recognized
by a variety of glycan-binding proteins, playing an important role in the bacteria
cross-talk with the host and invading bacteriophages, and also in the formation of
bacterial microcolonies and biofilms. In recent years, different microarray approaches
for exploring bacterial surface glycans and their recognition by proteins have been
developed. A main advantage of the microarray format is the inherent miniaturization
of the method, which allows sensitive and high-throughput analyses with very small
amounts of sample. Antibody and lectin microarrays have been used for examining
bacterial glycosignatures, enabling bacteria identification and differentiation among
strains. In addition, microarrays incorporating bacterial carbohydrate structures have
served to evaluate their recognition by diverse host/phage/bacterial glycan-binding
proteins, such as lectins, effectors of the immune system, or bacterial and phagic cell
wall lysins, and to identify antigenic determinants for vaccine development. The list of
samples printed in the arrays includes polysaccharides, lipopoly/lipooligosaccharides,
(lipo)teichoic acids, and peptidoglycans, as well as sequence-defined oligosaccharide
fragments. Moreover, microarrays of cell wall fragments and entire bacterial cells have
been developed, which also allow to study bacterial glycosylation patterns. In this review,
examples of the different microarray platforms and applications are presented with a
view to give the current state-of-the-art and future prospects in this field.
Keywords: bacterial glycans, microarrays, lectins, antibodies, immune system, vaccine development, bacterial
interactions
INTRODUCTION
The intricate network of glycans covering bacterial surfaces differs between Gram-negative and
Gram-positive bacteria (Figure 1) (Salton and Kim, 1996). Gram-negative bacteria are enveloped
by two cell membranes separated by a thin peptidoglycan layer, and display lipopolysaccharides
(LPSs) embedded in the outer membrane. LPSs are anchored to the membrane through a highly
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conserved lipid A moiety that is linked to a polysaccharide
composed of an inner and outer core and an outermost
chain built with repeating saccharide units, which is alluded
to as O-chain or O-antigen (Figure 1, left part). Some Gram-
negative bacteria, however, do not contain O-antigen chains in
their LPS, which is therefore referred to as lipooligosaccharide
(LOS). In contrast, Gram-positive bacteria only have one cell
membrane that is covered by a thick peptidoglycan layer,
and they usually display teichoic acids (TAs) anchored to
the membrane (known as lipoteichoic acids or LTAs) or
covalently bound to the peptidoglycan (known as wall teichoic
acids or WTAs) (Figure 1, middle part). Common to several
Gram-negative and -positive bacteria is the potential presence
of cell surface glycoproteins and capsular polysaccharides.
Mycobacteria can be considered apart from these two main
groups as they display a unique envelope distinguished by a
large cell wall complex formed by peptidoglycan covalently
attached to arabinogalactan, which in turn is linked to long
fatty acids (mycolic acids) that constitute the inner leaflet of
the so-called mycomembrane (Figure 1, right part) (Jankute
et al., 2015). Arabinomannan, lipoarabinomannan, phosphatidyl-
myo-inositol-mannosides, phenolic glycolipids, and trehalose-
containing lipids are other distinctive glycan structures of
the mycobacterial envelope (Figure 1, right part). Overall,
the repertoire of bacterial glycans shows a huge diversity in
monosaccharide residues and linkage configurations, many of
which are not found in the eukaryotic glycome (Figure 2) (Herget
et al., 2008; Adibekian et al., 2011). The precise structure of
these glycans may substantially differ among bacteria with the
same cell surface architecture, and even among different strains
of a given bacterial species. Moreover, some bacteria display
very rare sugars, e.g., 3,6-dideoxyhexoses, which are found in a
limited number of Enterobacteriaceae, or the 4,6-dideoxy sugar
anthrose, distinctive of Bacillus anthracis (Figure 2). Thus, the
specific glycans that decorate the bacterial surface can serve to
typify strains.
Many bacterial glycans are immunogenic and have been used
to develop vaccines against the respective bacteria. In addition,
they may be recognized as “non-self ” by host pattern-recognition
receptors, including a variety of lectins of the innate immune
system, for triggering defense mechanisms (Sukhithasri et al.,
2013; Wesener et al., 2017; Casals et al., 2018). Not surprisingly,
some bacteria camouflage from the host by displaying glycans
that mimic the carbohydrate moieties of host cells. Moreover,
recognition of such self-like glycans by host lectins may be
exploited by the bacterium for down-regulating the innate
immunity, or as stratagem for promoting attachment through
lectin bridging of bacterial and host glycans. On the other hand,
several bacteria bind directly to host glycans using surface-
exposed adhesins (Moonens and Remaut, 2017), and in some
cases these adhesins are also involved in the formation of
bacterial microcolonies and biofilms through binding to glycans
of neighbor cells or to secreted exopolysaccharides. Similarly,
bacteriophages frequently target bacterial glycans for invading
their hosts or to release the phage progeny. In addition,
many bacterial hydrolases, e.g., those hydrolyzing the cell
wall, are modular and contain carbohydrate-binding modules
(CBMs) that bind to specific regions of the substrate to situate
the catalytic domain at a position appropriate for cleavage.
Furthermore, there is a specific class of plant receptors able
to recognize bacterial oligosaccharides that operate as signaling
molecules in plant−bacteria symbiosis. Thus, a broad variety of
proteins from different life kingdoms recognize bacterial glycans
and play important roles in the cross-talk of bacteria with
their particular environment. Therefore, delineation of bacterial
surface glycosignatures and assessment of their recognition by
relevant glycan-binding proteins is crucial to understand, and
when possible govern, the bacteria’s behavior. To this aim,
different microarray approaches have been developed.
The microarray technology emerged to meet the scientist’s
desire of a high-throughput analytical tool that enabled
simultaneous analyses of a large number of biomolecular
interactions using very small amounts of sample. The underlying
concept was that a high local concentration of a given sample
clustered in a miniature spot could enhance detection sensitivity.
Prompted by the great success of DNA microarrays in gene
expression profiling and related applications (Morley et al.,
2004), protein (Zhu et al., 2001; Angenendt, 2005; Tao et al.,
2008) and carbohydrate microarrays were also developed (Fukui
et al., 2002; Blixt et al., 2004; Campanero-Rhodes et al., 2006),
allowing high-throughput studies of protein expression and
functionalities, including carbohydrate-mediated recognition
events (Blumenschein et al., 2007; Campanero-Rhodes et al.,
2007). Initially, most glycan libraries included in the arrays were
mainly composed of mammalian-like structures, casting doubt
on their value for exploring the binding preferences of proteins
that recognize bacterial glycans. To overcome this limitation,
growing efforts are being made to generate microarrays
incorporating bacterial carbohydrate structures, ranging from
small synthetic fragments to large natural polysaccharides.
Microarrays are frequently assembled on microscope glass
slides coated or derivatized with a variety of reagents, depending
on the nature of the samples to be immobilized (the probes) and
the surface chemistry of choice (please see Tables 1, 2 for selected
examples covered by this review). The binding of samples of
interest (the targets) to the arrays is then assessed, typically using
fluorescent detection systems that further enhance the sensitivity
of the technique (Figures 3, 4), although other methods have also
been used for detection (Figure 3 and Table 1).
This review gives different examples on the application of
the microarray technology to explore bacterial surface glycans
and their interactions with diverse glycan-binding proteins.
Lectin and antibody microarrays have served to examine
bacterial glycosignatures, facilitating bacteria identification and
differentiation among strains, and to spot variations in glycan
structures derived from changes in environmental conditions. In
addition, they have been exploited for detection of bacteria in a
diversity of samples, extending from sera to soils. Microarrays
incorporating bacterial carbohydrate structures have proved to
be useful for serodiagnosis of bacterial infections, identification
of antigenic determinants for vaccine development, and mapping
of epitopes recognized by bacteria-specific anti-carbohydrate
antibodies. Moreover, they have served to identify bacterial
ligands for lectins of the innate immune system and for bacterial
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FIGURE 1 | Bacterial glycans and architecture of the cell wall of different bacterial groups. Gram-negative bacteria (left part) contain a thin peptidoglycan layer,
sandwiched between two cell membranes, and display LPSs (composed of lipid A, inner and outer core, and O-chain) anchored to the outer membrane.
Gram-positive bacteria (middle part) contain a thick peptidoglycan layer, covering the cell membrane, and usually display teichoic acids anchored to the membrane
(lipoteichoic acids) or bound to the peptidoglycan. Gram-negative and -positive bacteria may also present cell surface glycolipids, glycoproteins, and a
polysaccharide capsule. Moreover, they may also secret different polysaccharides (known as exopolysaccharides) into the external environment. Representative
exopolysaccharide structures of cepacian (produced by B. cepacia), alginate, and Psl (produced by P. aeruginosa) are shown in the inset. Mycobacteria (right part)
contain a large cell wall complex formed by peptidoglycan, arabinogalactan, and mycolic acids of the so-called mycomembrane, and display other distinctive glycan
structures, such as lipomannan, lipoarabinomannan, phosphatidyl-myo-inositol-mannosides, and trehalose mycolates. Sugar residues are depicted using the
Symbol Nomenclature for Glycans (SNFG) (Varki et al., 2015; Neelamegham et al., 2019).
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FIGURE 2 | Monosaccharide residues found in bacteria, but not in mammals. Only those monosaccharides mentioned in the text have been included. ManNAc,
N-acetyl-mannosamine; FucNAc, N-acetyl-fucosamine; MurNAc, N-acetyl-muramic acid; PneuNAc; N-acetyl-pneumosamine; Rha, rhamnose; Abe, abequose; Par,
paratose; Tyv, tyvelose; Pse5Ac7Ac, 5,7-di-N-acetyl pseudaminic acid; Kdo, 3-deoxy-D-manno-oct-2-ulosonic acid; Ko, D-glycero-D-talo-oct-2-ulosonic acid; Hep,
L-glycero-D-mannoheptose; Ant, anthrose; Araf, arabinofuranose; Galf, galactofuranose.
and phagic proteins. Finally, microarrays of cell wall fragments
and entire bacterial cells have been used to profile accessible
carbohydrate structures on the bacterial surface, and to examine
their interactions when they are displayed on the cell surface, thus
preserving their natural arrangement, distribution, and density.
LECTIN MICROARRAYS FOR
GLYCOPHENOTYPING OF BACTERIA
A diversity of lectin microarrays has been developed and applied
to the analysis of the glycosylation profiles of different bacteria,
also enabling differentiation among strains of a given bacterium,
and to monitor variations in their glycosignatures associated
with changes in culture conditions. These microarrays exploit
the ability of lectins to selectively recognize specific carbohydrate
structures on the bacterial surface. An example is the comparison
of the binding patterns of Escherichia coli (laboratory strain
DH5α), Enterobacter cloacae, Staphyloccocus aureus (Rosenbach),
and Bacillus subtilis to an array of 16 lectins with various
carbohydrate-binding specificities (Gao et al., 2010). A peculiarity
of this study was the detection of bound bacteria using gold
nanoparticles functionalized with Griffonia simplicifolia lectin
II (GSL-II), which is specific for N-acetylglucosamine (GlcNAc,
please see Table 3 for detailed information on the binding
specificities of model lectins mentioned in this review) and
was shown to recognize the four bacteria, followed by silver
deposition to enhance the resonance light scattering of the
particles, finally used for quantitation (Figure 3 and Table 1).
Clearly different binding patterns were observed, with distinctive
features for each bacterium. For example, whereas strong binding
of E. coli, E. cloacae, and B. subtilis by the galactose (Gal)-
specific agglutinins from Ricinus communis (RCA) and Maackia
amurensis (MAA-I), and by the sialic acid-specific M. amurensis
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TABLE 1 | Lectin and antibody microarrays used for glycophenotyping, differentiation, and detection of bacteria.
Printed probes Slide surface
chemistrya
Tested targets Detection strategy Detection technique References
16 Lectins Epoxy activated E. coli, E. cloacae,






Gao et al., 2010
15 Lectins NHS activated
polyacrylamide hydrogel
coating




Liu et al., 2016
21/41 Lectins NHS activated
multi-component
hydrogel coating





Fluorescence scanning Hsu et al., 2006
Kilcoyne et al., 2014






Yasuda et al., 2011
8/15 Lectins + 2
Abs
Epoxy activated C. jejuni LOS (3/8 strains) LOS labeled with
BODIPY
Fluorescence scanning Semchenko et al.,
2012a
ConA ZnO nanorod arrays on
fluorine-doped tin oxide
glasses
E. coli DAPI labeling of bound
bacteria
Fluorescence microscopy Zheng L. B. et al., 2017








Saucedo et al., 2018
Anti-E. coli
O157:H7 Ab
Gold slides coated with
biotin-labeled BSA +
streptavidin (for printing of
biotin-labeled Ab)
E. coli O157:H7 Fluorescein-labeled
anti-E. coli O157:H7 Ab
Fluorescence microscopy Gehring et al., 2006
6 Abs + 6 O-chain
polysaccharides













SPR imaging Mondani et al., 2016





Fluorescence scanning Cai et al., 2005
Marimon et al., 2010
aGlass slides unless otherwise indicated; NHS, N-hydroxysuccinimide; SPR, surface plasmon resonance; Ab, antibody.
lectin II (MAA-II) was observed, this was not the case for
S. aureus, whose binding pattern was additionally characterized
by the intensity of the signal for the fucose-specific Aleuria
aurantia lectin (AAL). On the other hand, B. subtilis was
distinguished by the binding signals for the lectins from Erythrina
cristagalli (ECL) and, specially, Datura stramonium (DSL), while
E. coli gave the strongest signal among the four bacteria tested
for soybean agglutinin (SBA). Interestingly, signal intensities and
binding patterns of E. coli and S. aureus appeared to change when
these bacteria were grown in different culture media, suggesting
variations in their surface glycans. An intriguing result of this
study was the low signal observed for the binding of S. aureus by
wheat germ agglutinin (WGA), particularly when compared with
GSL-II as WGA also recognizes GlcNAc (see Table 3). Indeed, a
later study of these authors using different procedures for lectin
immobilization and detection of bacterial binding (specified in
Table 1) showed comparable binding signals of the same S. aureus
strain for WGA and GSL-II (Liu et al., 2016). This discrepancy
could tentatively be explained by a different binding activity
of printed WGA, possibly derived from the immobilization
strategies employed, and draws attention to the importance of
using appropriate internal controls of lectin activity.
Besides providing information on the glycosylation profiles
of different bacteria, lectin microarrays can aid to differentiate
strains of a given bacterium. This was first demonstrated by Hsu
et al. (2006), who compared the lectin binding fingerprints of two
closely related K12 E. coli strains (defective in O-chain synthesis)
and of E. coli RS218, a neonatal meningitis pathogen. Using
a panel of 21 lectins, whose binding activity was verified with
fluorescently-labeled glycoprotein standards, clear differences in
binding patterns and intensities were observed. In particular,
the two K12-derived strains showed strong binding by GSL-
II, WGA, and the α-N-acetylgalactosamine (α-GalNAc)-specific
lectin from the snail Helix pomatia (HPA), but only one
of them gave meaningful binding signals with four other
lectins, suggesting the presence of different repertoires of
surface glycan structures. This was even more evident for
the pathogenic E. coli strain, which gave positive signals with
10 lectins of the panel. Since the invasiveness of E. coli
RS218 was known to be growth dependent, the possibility
that the lectin binding patterns could also change with growth
was examined. A general decrease in the intensities of all
the positive signals was observed when progressing from
the lag phase to the stationary phase (Hsu et al., 2006),
suggesting a possible correlation of glycosylation with invasion.
Overall, the approach proved to be useful for distinguishing
E. coli strains and monitoring dynamic alterations in the cell
surface glycans.
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FIGURE 3 | Illustration of different lectin and antibody microarray approaches used for glycophenotyping, differentiation, and detection of bacteria. Top panel:
Microarrays containing a collection of lectins with diverse carbohydrate-binding specificities can be incubated with fluorescently-labeled bacteria or LOS and bound
targets directly quantified using a fluorescence microarray scanner (upper row). Alternatively, the microarrays can be incubated with unlabeled bacteria and bound
bacteria next labeled with a fluorescent dye, enabling detection by confocal microscopy (middle row). Bound unlabeled bacteria can also be detected by incubation
with gold nanoparticles conjugated to a lectin known to recognize the bacteria under study. The resonance light scattering (RLS) of the nanoparticles is then
enhanced by deposition of silver and next measured using a colorimetric microarray scanner (lower row). Bottom panel: Microarrays containing antibodies (Abs)
raised against selected bacteria can be incubated with fluorescently-labeled bacteria and bound bacteria detected by fluorescence scanning (upper row). The
microarrays can also be incubated with unlabeled bacteria, followed by incubation with fluorescently-labeled anti-bacteria Abs, and bound Abs are next detected by
confocal microscopy (middle row). Finally, bacteria selectively bound by Abs arrayed on SPR (surface plasmon resonance) chips can be detected by monitoring
their growth during on-chip culture, using SPR imaging (lower row). Specific bacteria that have been tested using these different approaches are detailed in each
case.
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A similar approach was exploited to compare the lectin
binding patterns of 16 Lactobacillus casei/paracasei strains
indistinguishable from each other by 16S rRNA sequences
(Yasuda et al., 2011). Using a panel of 44 lectins, a unique binding
fingerprint was observed for 13 of these strains. Interestingly, half
of the strains were bound by only one or two lectins, whereas
the rest were recognized by multiple lectins with different
carbohydrate-binding specificities, again pointing to a diversity
of glycan structures. Thus, the assays enabled differentiation
of strains, at the same time providing information on the
carbohydrate determinants on the bacterial surface that are
accessible for recognition.
Campylobacter jejuni is responsible for gastroenteritis in
humans, while it is a commensal in chicken. A main difference
between human and avian hosts is their core body temperature
(37 and 42◦C, respectively), what could be important for
specific adaptation and ensuing pathogenesis or commensalism
outcomes. In order to explore the effect of temperature on
the surface glycans, two strains isolated from human hosts,
the highly virulent C. jejuni 81-176 and the comparatively less
invasive C. jejuni 81116, were cultured at 37 and 42◦C and
their lectin binding patterns were examined using a microarray
comprising 41 lectins, whose binding activities were verified
with fluorescently-labeled control glycoproteins (Kilcoyne et al.,
2014). Distinctive hapten-inhibitable binding patterns for strains
grown at 37◦C were observed, being in general compatible with
known structures of their surface glycans. For strain 81116
cultured at 42◦C, an important decrease in the most intense
binding signals was observed. These signals corresponded to
lectins specific for Gal, lactose (Galβ(1-4)Glc), or GlcNAc, which
are present in the LPS-like structure described in this strain, thus
pointing to a decreased expression or alteration of this structure.
In contrast, the changes in the lectin fingerprint of the virulent
strain 81-176 grown at 42◦C were more subtle, with only a
subset of lectins showing small variations in binding intensity.
This implied a relatively constant repertoire of glycan structures
accessible for recognition. Based on the binding specificity of
the lectins involved, these structures most probably include the
capsular polysaccharide (CPS) and the LOS, which are known to
play different roles in adhesion and invasion of epithelial cells as
well as evasion of the immune system.
Campylobacter jejuni produces a variety of LOS structures
that mimic mammalian gangliosides, what is thought to induce
anti-ganglioside antibodies in the host and the subsequent
development of neuropathies. A mixed lectin and antibody array
was used to screen the LOS of C. jejuni strains for molecular
mimicry (Semchenko et al., 2012a,b). First, a panel of 8 lectins,
including cholera toxin subunit B (CTB), which binds ganglioside
GM1, together with two antibodies against gangliosides GM1 and
GM2 as positive controls, were used to examine LOS preparations
from strains 11168-O (known to mimic GM1), 81-176 (GM2
like), and 224 (unknown LOS type) (Semchenko et al., 2012b).
Surprisingly, none of the LOS was bound by CTB, what could be
due to a loss of lectin activity upon incorporation into the array,
again stressing the importance of verifying the activity of printed
lectins. The LOS from strain 11168-O gave strong binding signals
for the Gal-specific agglutinins from Arachis hypogaea (PNA),
Viscum album (VAA), and Artocarpus integrifolia (jacalin), in
agreement with the presence of terminal Gal as found in
GM1, whereas a significantly lower binding by these lectins was
observed for the LOS from strain 81-176, compatible with the
absence of terminal Gal in its GM2-like structure. In comparison,
although the LOS from strain 224 was bound by the anti-GM1
antibody, the binding signals for the Gal-specific lectins were
equal to those observed for 81-176 rather than 11168-O. Using
an extended array comprising 15 lectins, the binding patterns
of the LOS from these three and five other uncharacterized
C. jejuni strains were next examined (Semchenko et al., 2012a).
Intriguingly, in this study no significant binding by VAA was
observed for LOS 11168-O, indicating that, besides the procedure
used for lectin printing, other factors, as, e.g., the activity of
the specific lectin preparation employed, may affect the results.
Based on the comparison of the antibody and lectin patterns
of the uncharacterized LOSs with those of C. jejuni 11168-
O- and 81-176-derived LOSs (with known GM1- and GM2-
like structures, respectively), their terminal end structures were
proposed. A parallel typing of LOS biosynthesis cluster, using
a standard PCR method, revealed that the cluster type alone
does not always allow prediction of the real LOS structure,
highlighting the usefulness of the lectin microarray approach
as complementary tool for evaluating the potential of clinical
C. jejuni isolates to induce adverse autoimmune reactions.
The capture of bacteria by lectin arrays can also be exploited
for detection of pathogenic bacteria in the clinical field as well
as in the environmental or agri-food sectors. A ZnO nanorod
array functionalized with concanavalin A (ConA), a mannose
(Man)/glucose (Glc)-specific lectin from the legume Canavalia
ensiformis, was employed for capturing E. coli (Table 1) and
proved to work efficiently with reasonable detection limits and
linear range (1.0 × 103 to 1.0 × 107 cfu mL−1) even in
complex samples, so it could be applied to the analysis of real
samples (Zheng L. B. et al., 2017). More recently, a lectin and
saccharide nano-chemiresistor array was used to detect E. coli
K12, Enterococcus faecalis, Streptococcus mutans, and Salmonella
enterica sv. Typhi (Saucedo et al., 2018). The array consisted in
carbon nanotubes assembled on the surface of gold electrodes
and functionalized with three lectins (ConA, PNA, and WGA)
and three aminophenyl saccharides (Gal, Glc, and Man). After
incubation with bacteria, changes in the electronic properties
were monitored by measuring device resistance. E. coli and S.
Typhi, both Gram-negative bacteria, gave noticeably different
patterns, whereas for Gram-positive E. faecalis and S. mutans the
patterns were more similar, although still clearly distinguishable.
Detection was achieved at clinically relevant concentrations,
indicating that an array with carefully chosen probes could be
used as diagnostic tool.
ANTIBODY MICROARRAYS FOR
DETECTION AND SEROTYPING OF
BACTERIA
Bacterial surfaces display a variety of antigens that can be used
for identification and typing of antigenically distinct strains.
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Different microarrays incorporating O-antigen- or capsular-
specific antibodies have been used to this aim. One example is
the detection of Shiga-toxin producing E. coli (STEC), which
is frequently identified as the pathogen responsible for food-
illnesses and causes severe enteric infections such as diarrhea,
hemorrhagic colitis, or even hemolytic uremic syndrome, a
life-threatening complication. E. coli O157:H7 was the first
enterohemorrhagic E. coli serotype detected in an outbreak in
United States provoked by the consumption of contaminated
burgers. The potential of antibody microarrays for detecting
the bacterium was put forward by Gehring et al. (2006), who
used a polyclonal anti-E. coli O157:H7 antibody printed onto
microarray slides (Table 1) for capturing E. coli O157:H7 cells,
in turn detected with fluorescently-labeled anti-E. coli O157:H7
antibody (sandwich fluorescent immunoassay, see Figure 3).
A linear fluorescent response was observed from ∼3.0 × 106
to ∼9.0 × 107 cells/mL. A similar sandwich immunoassay was
later used for identification of six other STEC serogroups, i.e.,
O26, O45, O103, O111, O121, and O145 (the top six non-
O157 serogroups), which have been associated with 70–80% of
non-O157 STEC-produced illnesses. Microarrays incorporating
antibodies specific for one of these six O-antigens, along with
the respective O-antigen polysaccharides as positive control,
were tested for the binding of reference strains belonging to
these serogroups and found to yield specific and reproducible
signals at bacterial concentrations of 106 CFU/mL and above
(Hegde et al., 2013). STEC can represent a serious threat to
human health at very low contaminating levels (less than 100
CFU per sample), far below the limits of detection of this
microarray approach and of other techniques commonly used.
Consequently, a pre-enrichment step is always required. Several
foods have been identified as potential sources of STEC, including
tap water, but the main source and reservoir is beef. Indeed,
a recent outbreak in United States has been associated with
the consumption of ground beef contaminated with E. coli
O1031. Therefore, the efficiency of the antibody microarray for
serotyping contaminant non-O157 STEC in food was evaluated
by testing ground beef samples enriched for 12 h after inoculation
with 1–10 CFU of target serogroups, alone or in combination
with one or two other serogroups (Hegde et al., 2013). All target
groups were identified with no cross reactions, supporting the
usefulness of the approach for the simultaneous detection of
different STEC serogroups.
An antibody microarray approach for fast detection of O157
and the top six non-O157 STEC serogroups without the need of a
pre-enrichment step was reported by Mondani et al. (2016). The
approach was based on the on-chip culture of bacteria captured
by the arrayed antibodies (Figure 3), and real-time monitoring of
bacterial growth by surface plasmon resonance imaging (SPRi),
a method previously found to be efficient for detecting E. coli
O157:H7 at very low initial concentrations (Bouguelia et al.,
2013; Mondani et al., 2014). Fifteen different strains belonging
to the seven STEC serogroups, plus two non-STEC strains,
were analyzed on SPR biochips presenting electrochemically
arrayed antibodies against the target serogroups (Table 1).
1https://www.cdc.gov/ecoli/2019/o103-04-19/index.html
All STEC serogroups were successfully identified, even at
initial concentrations in the range encountered in naturally
contaminated samples (few CFU ml−1), and no response was
observed for the non-STEC strains. Moreover, E. coli O157:H7
was successfully detected in ground beef artificially contaminated
with only few cells (5 CFU per 25 g). Thus, considering that
detection of bacteria is carried out during enrichment, thereby
reducing the processing time, the approach could be a faster
alternative to other methods commonly used for detection of
STEC in contaminated food.
Antibody microarrays have also proved to be useful for
high-throughput serotyping of bacteria. As example, microarrays
incorporating antisera against selected Salmonella O and
H (flagellar proteins) antigens were efficient for serotyping
S. enterica strains (Cai et al., 2005). Using 117 target strains,
belonging to the top 20 commonly isolated and clinically relevant
serotypes, and 73 non-target strains, this microarray approach
successfully allowed one-step full or partial identification of 86
and 30 target strains, respectively, and exclusion of all non-
target strains.
In the case of Streptococcus pneumoniae, the capsule is
one of the major pathogenicity factors. Currently, 98 different
serotypes, divided into 25 individual types and 21 serogroups,
composed of two to eight serotypes with related capsular
antigenic determinants that can be differentiated using factor
(individual capsular antigen) antisera, have been identified.
A microarray containing 66 different group-, type- and factor-
specific antisera, with specificity for 83 of the 98 S. pneumoniae
serotypes, was first tested with S. pneumoniae reference isolates
of these 83 serotypes and found to correctly serotype 94% of the
samples. Only 11 isolates within the same group were mistyped
and for four samples a detectable signal was not obtained
(Marimon et al., 2010). To test the utility of the microarray in
clinical practice, 226 S. pneumoniae clinical isolates (106 invasive
isolates and 120 randomly-selected non-invasive isolates) were
next examined, in direct comparison to serotyping by latex
agglutination followed by the Quellung reaction. Only for 7.1%
of the isolates discrepant serotyping by the two methods was
found. Moreover, for these isolates, PCR amplification of each
capsular gene showed that only one isolate was misidentified by
the microarray. Thus, the microarray approach proved to be an
accurate serotyping technique and could be a valuable tool for
pneumococcal epidemiological studies.
BACTERIAL GLYCAN ARRAYS FOR
SERODIAGNOSIS OF BACTERIAL
INFECTIONS
Exposure to bacterial antigens often induce the production of
antibodies. A seminal study of Wang et al. (2002) demonstrated
the usefulness of microbial glycan microarrays for detecting the
presence in human serum of antibodies against several bacteria.
An array incorporating a collection of carbohydrate-containing
macromolecules, including 21 bacterial polysaccharides, was
incubated with 1-µl human serum samples from normal
individuals, and IgG and IgM antibodies captured in the
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TABLE 2 | Bacterial carbohydrate microarrays used for detection of bacteria-specific anti-carbohydrate antibodies and for recognition studies targeting diverse glycan
binding proteins.





NHS activated Human/mice sera,
human fecesb,
hybridoma supernatant
Oberli et al., 2011
Martin et al., 2013b
Broecker et al., 2016a
Polysaccharides and synthetic





NHS activated Human/mice/rabbit sera,
mAbs
Geissner et al., 2016
Parameswarappa et al.,
2016
Emmadi et al., 2017
Lisboa et al., 2017
Menova et al., 2018
Seeberger et al., 2017
Menova et al., 2018




Probes coupled to BSA Epoxy activated Human/mice sera Chen et al., 2016
Prados-Rosales et al., 2017
Library of bacterial CPSs Direct adsorption of
unmodified probes
Nitrocellulose Human sera Wang et al., 2002




NHS activated Rabbit Salmonella typing
sera, human sera
Blixt et al., 2008
Library of LPS O-chains + core Unmodified probes or
equipped with amino-linker
NHS activated Langerin, galectins 3, 4, 8, 9,
Gp047
Feinberg et al., 2011
Stowell et al., 2014
Knirel et al., 2014 Javed
et al., 2015







Human/mice sera, SP-D Reinhardt et al., 2015
Reinhardt et al., 2016
Library of LPSs Direct adsorption of
unmodified probes







gamma amino propyl silane
Anti-ManLAM mAb, DC-SIGN Chan et al., 2015
Leelayuwapan et al., 2017




NHS activated Human sera, human fecesb Martin et al., 2013a





Epoxy activated Anti-S. epidermidis mAb,
rabbit sera









Wang et al., 2016








NHS activated P60 autolysin, synthetic LysM
domain
Maolanon et al., 2014




conjugation of probes to the
aminolipids ADPH (reductive
amination) or AOPE (oxime
ligation)
Nitrocellulose Anti-glucan mAbs, Dectin-1
DC-SIGN, DC-SIGNR,
bacterial CBMs
Palma et al., 2006
Palma et al., 2015
Zhang et al., 2016
Li and Feizi, 2018
Cyclic β(1-2)-glucans Probes embedded in a 3D
matrix of a photoactive
terpolymer










Anti-B. anthracis spore Abs,
anti-di/tetrasaccharide mAbs,
cattle sera
Wang et al., 2007
Oberli et al., 2010
Tamborrini et al., 2011
Burkholderia pseudomallei CPS




Epoxy activated Human sera Parthasarathy et al., 2006






Epoxy activated Human sera Tong et al., 2005
M. tuberculosis lipid-linked
glycans and polysaccharides
Unmodified probes Nitrocellulose Human ZG16p lectin Hanashima et al., 2015
(Continued)
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TABLE 2 | Continued





amino-linker and coupled to
BSA
Epoxy activated DC-SIGN, DC-SIGNR,
Dectin-2, langerin, MGR,
mannose receptor, mincle
Zheng R. B. et al., 2017
Library of diverse synthetic
bacterial structures






lectins A and C-Ctc
Geissner et al., 2019




NHS activated Human sera, mice/rabbit
Abs, galectins 3, 4, 8,
langerin, intelectin-1
Stowell et al., 2014
Wesener et al., 2015
Hanske et al., 2017
aGlass slides unless otherwise indicated; bSupernatant of human feces; cC-terminal domain of B. cenocepacia lectin C; NHS, N-hydroxysuccinimide;
ADPH, N-aminoacetyl-N-(9-anthracenylmethyl)-1,2-dihexadecyl-sn-glycero-3-phosphoethanolamine; AOPE, 1,2-dihexadecyl-sn-glycero-3-phosphoethanolamine; MGR,
macrophage galactose receptor; Ab, antibody.
array were independently detected using the respective anti-
human IgG/IgM secondary antibodies (see Figure 4 for
a schematic representation of different strategies used for
fluorescent detection of target binding to bacterial carbohydrate
microarrays). IgM binding to pneumococcus type 27 and
different Klebsiella polysaccharides was spotted, and the
repertoire of bacterial polysaccharides recognized by IgG
antibodies was broader, also including E. coli types K92 and
K100, group B meningococcus, Haemophilus influenzae type A,
and 5 different pneumococcus types. These results questioned
the traditional belief that naturally occurring anti-polysaccharide
antibodies were mainly of IgM type, and demonstrated that the
proposed system was efficient for detecting specific antibodies
in human serum. Moreover, a microarray containing a panel
of nine LPS preparations isolated from different bacteria,
including Francisella tularensis, was later found to be efficient
for detecting anti-F. tularensis LPS antibodies in tularemia-
positive canine serum samples (Thirumalapura et al., 2005),
while more focused arrays containing capsular and O-antigen
saccharides from different strains of Burkholderia mallei
and/or Burkholderia pseudomallei successfully detected specific
antibodies in the serum of human patients infected with these
bacteria (Parthasarathy et al., 2006, 2008). Altogether, these
studies revealed the potential of bacterial glycan microarrays for
the serological diagnosis of bacterial infections.
Different types of bacterial glycans have been included in the
arrays (Table 2), essentially depending on the specific bacterium
under study. For example, several Salmonella serogroups
are characterized by displaying O-antigens containing 3,6-
dideoxy-D-ribo- (paratose, abbreviated Par, serogroup A), -
D-xylo- (abequose, abbreviated Abe, serogroup B), or -D-
arabino- (tyvelose, abbreviated Tyv, serogroup D) hexose residues
(Figure 2), α(1-3)-linked to a common Manα(1-4)Rhaα(1-3)Gal
main chain (Rha standing for rhamnose). A microarray including
synthetic di-, tri-, and tetrasaccharide glycosides based on these
regions was tested with group-specific anti-Salmonella rabbit
sera, showing a rather selective IgG binding to the respective
O-antigens (Blixt et al., 2008). Based on the high specificity
observed for the disaccharides Tyvα(1-3)Manα, Parα(1-3)Manα,
and Abeα(1-3)Manα, their ability to detect Salmonella-specific
antibodies in the serum of patients infected with S. enterica
sv. Enteritidis (serogroup D) or S. enterica sv. Typhimurium
(serogroup B) was examined in comparison to healthy controls.
The first group of patients showed significantly elevated levels
of antibodies against Tyvα(1-3)Manα, whereas the second group
showed high reactivity toward Abeα(1-3)Manα, in both groups
Parα(1-3)Manα giving only background signals. Therefore,
O-antigen specific microarrays could be a suitable tool for
serodiagnosis of Salmonella infections.
Mycobacteria display surface glycoconjugates very different
from those of most other bacteria (Figure 1 right part). Tong
et al. (2005) developed a multiplexed assay for serodiagnosis of
tuberculosis based on a microarray containing 54 antigens of
different classes, i.e., fractions of Mycobacterium tuberculosis
cells and culture fluid, oligosaccharides conjugated to bovine
serum albumin (BSA), purified LPSs and polysaccharides, and
recombinant antigens. The goal was to identify antigens, or
combinations thereof, allowing discrimination between culture-
positive pulmonary tuberculosis patients, culture-negative
patients with other pulmonary diseases, and healthy individuals.
The authors found that a BSA conjugate containing the branched
structure Araβ(1-2)Araα(1-3)[Araβ(1-2)Araα(1-5)]Araα(1-
5)Ara of the cell wall glycolipid lipoarabinomannan (LAM,
Figure 5), on its own, discriminated with good specificity and
sensitivity between tuberculosis and non-tuberculosis sera,
pointing out the applicability of LAM in serological tests.
BACTERIAL GLYCAN ARRAYS FOR
IDENTIFICATION OF NOVEL VACCINE
CANDIDATES
Development of efficient vaccines to prevent bacterial infections
can be facilitated by microarray-assisted identification of
bacterial structures inducing an immune response and analysis
of the specific epitopes recognized by vaccine-elicited protective
antibodies. In tuberculosis patients, for example, antibody
responses to LAM and to the related capsular polysaccharide
arabinomannan (AM) correlate strongly, suggesting that AM is
the immunogenic portion of LAM. A microarray containing a
panel of 12 synthetic AM fragments, coupled to BSA, was used
to assess the reactivity of IgG antibodies in the sera of 30 healthy
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FIGURE 4 | Schematic representation of different strategies used for fluorescence-based detection of lectin and antibody (Ab) binding to bacterial carbohydrate and
whole cell microarrays. The simplest setup involves incubation with a fluorescently labeled target (lower right side). A common strategy is the use of biotinylated
targets, which are next detected by incubation with fluorescently labeled streptavidin (upper part). The targets may carry other tags (e.g., His- or Fc-tags), and
detection then has involved the use of biotinylated or unlabeled Abs, followed by incubation with streptavidin or with a biotinylated secondary Ab, as appropriate.
Pre-complexing tagged targets with primary and secondary Abs has been exploited to reduce the number of incubation steps and/or to increase the sensitivity of
detection. Alternatively, tagged targets have been detected by incubation with a fluorescent or unlabeled Ab, the latter followed by incubation with a fluorescent
secondary Ab (lower part). Finally, the binding of unlabeled targets has been monitored using biotinylated or unlabeled primary Abs followed by fluorescently labeled
streptavidin or secondary Abs. In all cases, the final step involves the scanning of fluorescence signals.
M. tuberculosis-uninfected adults before and after primary or
secondary vaccination with the licensed bacillus Calmette-Guerin
(BCG) vaccine (Chen et al., 2016). In both vaccination groups,
sera obtained 4 and 8 weeks after vaccination had significantly
higher levels of AM-specific IgGs, although heterogeneous
binding patterns to the microarray-printed AM fragments were
observed. Interestingly, increased IgG titers correlated with
enhanced BCG phagocytosis, particularly with IgG reactivity to
three particular AM epitopes that contained at least two Man
residues. Overall, the results suggested that AM-specific IgGs
contribute to the defense against mycobacterial infection in
humans. Moreover, immunization with AM-protein conjugates
was also found to contribute to protection against infection
(Prados-Rosales et al., 2017). In detail, immunization of mice
with a 20 kDa AM fraction conjugated to M. tuberculosis Ag85b
or to protective antigen from B. anthracis resulted in elevated
levels of AM-specific antibodies able to stain M. tuberculosis cells,
as observed by electron microscopy. To gain insight into the AM
epitopes recognized by the antibodies, the binding of immune
sera to a microarray including 30 BSA-conjugated synthetic AM
fragments (representative of the mannan backbone, branched
arabinan, and terminal Man residues) was examined. Binding
to a diversity of fragments was observed, the most prevalent
being linear or branched arabinan structures. Importantly,
immunized mice next infected with the bacterium had lower
bacterial loads in lungs and spleen and lived longer than
control mice, with a marked reduction in mycobacterial
dissemination. Thus, the humoral arabinan-targeted response
elicited by the AM-protein conjugates can importantly contribute
to the outcome of mycobacterial infection, suggesting that
AM could be a good candidate for developing new vaccines
against M. tuberculosis.
The glycan chain of the B. anthracis exosporium glycoprotein
BclA, which decorates the surface of B. anthracis spores, also
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contains a unique tetrasaccharide structure consisting of 2-
O-methyl-4-(3-hydroxy-3-methylbutamido)-4,6-dideoxy-Glc
(termed anthrose and abbreviated Ant, Figure 2) β(1-3)-
linked to Rhaα(1-3)Rhaα(1-2)Rha. A microarray including
synthetic fragments and derivatives of this tetrasaccharide
was examined for the binding of pooled rabbit polyclonal
anti-anthrax spore IgG antibodies, revealing the presence
of antibodies binding to anthrose-containing tri- and tetra-
saccharides (Wang et al., 2007). Thus, the glycan chain of
BclA appeared to be immunogenic and could be employed to
develop novel vaccines targeting anthrax spores. In fact, mice
immunization with the tetrasaccharide or with Antβ(1-3)Rha
was later proved to elicit an antibody response, enabling the
generation of monoclonal IgGs (Oberli et al., 2010). The binding
specificity of several anti-tetrasaccharide and anti-disaccharide
monoclonal antibodies (mAbs) was examined by microarray
screening using a series of synthetic mono- to tetrasaccharides
equipped with different anthrose side chain appendages. The
anti-disaccharide mAbs recognized all the structures with intact
anthrose, including anthrose monosaccharides, whereas the
anti-tetrasaccharide mAbs required at least two Rha units as
well as the terminal anthrose for tight binding. Although small
modifications of the anthrose side chain only significantly
affected anti-tetrasaccharide mAb binding, a drastic chain
truncation abolished binding for all mAbs. Altogether, the results
demonstrated that anthrose is the primary recognition unit.
Interestingly, an anthrose-deficient B. anthracis lineage was
identified in cattle from West Africa (Tamborrini et al., 2011),
where anthrax is highly endemic and the majority of vaccines for
cattle are based on live spores from an anthrose-positive strain.
Thus, the spread of anthrose-deficient strains in this region could
be an escape strategy of B. anthracis.
Microarrays containing synthetic structures based on TAs
have also proved to be efficient for detecting anti-TA antibodies
in serum (Table 2). A library of compounds comprising the most
common glycerol phosphate backbone with 15 monomers in
length, decorated by α-Glc, α-GlcN (glucosamine) or α-GlcNAc
residues at various positions of the main chain (Figure 5), was
interrogated for the binding of a mouse anti-Staphylococcus
epidermidis mAb, serum obtained from rabbits immunized with
E. faecalis LTA, and rabbit serum raised against a BSA-TA
conjugate (van der Es et al., 2018). Clearly different IgG/IgM
binding patterns were observed, unveiling selective recognition
of specific TA epitopes and posing that TA-based vaccination
strategies could be possible. Indeed, the potential of LTA
glycans as vaccine candidates to protect from Clostridium difficile
infections was previously proposed. This bacterium contains
an unusual LTA phosphodiester-linked repeating unit with
the sequence -6)GlcNAcα(1-3)[P6]-GlcNAcα(1-2)GroA (GroA
being glyceric acid) (Figure 5). A microarray-printed synthetic
dimer of this repeating unit was used to assess the binding
of IgG antibodies in the serum of C. difficile-infected patients,
unveiling recognition in six out of 12 tested samples and thereby
suggesting that this epitope could be a relevant C. difficile
antigen (Martin et al., 2013a). In a later study (Broecker
et al., 2016b), a conjugate of the dimer and the carrier protein
CRM197, a constituent of licensed vaccines, was used to immunize
mice, and antibody responses in serum were followed using
microarrays containing the dimer as well as monomers of
the repeating unit with one or two phosphorylated GlcNAc
residues. The results revealed that the conjugate elicited anti-
LTA antibodies for which the minimal epitope for recognition
was the repeating unit. Importantly, sera of immunized mice
significantly opsonized all C. difficile strains and clinical isolates
investigated. Moreover, colonization by C. difficile in immunized
mice orally challenged with live bacteria was reduced compared
with control mice. Thus, C. difficile LTA glycans emerged as
potential vaccine candidates.
Two different C. difficile CPSs, named PS-I and PS-II, were
also found to be antigenic and immunogenic. Both CPSs are
present in a hypervirulent C. difficile strain responsible for
outbreaks in North America and Europe. PS-I has a branched
pentaglycosyl phosphate repeating unit [-4)Rhaα(1-3)Glcβ(1-
4)[Rhaα(1-3)]Glcα(1-2)Glcα(1-P], while PS-II has a branched
hexaglycosyl phosphate repeating unit [-6)Glcβ(1-3)GalNAcβ(1-
4)Glcα(1-4)[Glcβ(1-]GalNAcβ(1-3)Manα(1-P] (Figure 5)
(Ganeshapillai et al., 2008). First, the non-phosphorylated PS-II
hexasaccharide was synthesized, conjugated to CRM197, and
used to immunize mice (Oberli et al., 2011). Binding assays to
the microarray-printed hexasaccharide showed the presence
of specific IgG antibodies in the serum of immunized mice,
indicating that the hexasaccharide was immunogenic. Moreover,
specific IgA antibodies were detected in the feces of patients with
C. difficile infection (Oberli et al., 2011; Martin et al., 2013b),
suggesting that PS-II could be an antigenic determinant
in humans. The non-phosphorylated PS-I pentasaccharide,
together with mono-, di-, and tri-saccharide substructures
thereof, were also synthesized and used for microarray screening
of specific IgAs in feces and IgGs in serum of C. difficile-infected
patients, in comparison to other patients and healthy controls.
Variable antibody levels were detected in all groups, indicating
that these structures represent biologically relevant epitopes.
The main antigenic determinant of the pentasaccharide was
explored by examining the binding to the arrays of sera of mice
immunized with a PS-I pentasaccharide-CRM197 conjugate
and of mAbs generated from such sera using the hybridoma
technique (Broecker et al., 2016a), revealing that the disaccharide
Rhaα(1-3)Glc, which is found twice in the pentasaccharide, is a
minimal size epitope. Therefore, a simple disaccharide could be a
valid target for developing novel vaccination approaches against
C. difficile. Compared to the disaccharide, a construct displaying
five disaccharide units showed noticeably tighter binding (about
five orders of magnitude) to the mAbs and elicited in mice an IgG
response more specific for larger glycans (Broecker et al., 2016a),
thus limiting cross-reaction with structurally related glycans.
The antigenic CPS determinants of different S. pneumoniae
serotypes were also investigated using a similar strategy, i.e.,
synthesis of the repeating unit and substructures thereof,
construction of microarrays incorporating these synthetic
structures, and screening of relevant sera for detection of
recognized structures, often complemented with immunization
of mice or rabbits with CRM197-conjugates of selected structures
and subsequent microarray-assisted evaluation of serum
antibodies and mAbs. Clearly distinct determinants were
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identified in each case. Thus, in serotype 2 the GlcAα(1-
6)Glcα(1-2) branch (GlcA being glucuronic acid) was found to
be an important substructure of the hexasaccharide repeating
unit (Emmadi et al., 2017), while in serotype 7F the two side
chains that decorate the linear tetrasaccharide backbone, i.e.,
Galβ(1- and GlcNAcα(1-2)Rhaα(1-, played a key role (Menova
et al., 2018). Gal modification with a pyruvate ketal in the
linear tetrasaccharide unit of serotype 4 was observed to be
an important determinant, although pyruvate-independent
epitopes were also unveiled (Geissner et al., 2016), whereas
in the serotype 5 pentasaccharide unit the rare aminosugar
N-acetyl-L-pneumosamine (PneuNAc, Figure 2) together with
branched N-acetyl-L-fucosamine (FucNAc) were essential for
antibody recognition and avidity (Lisboa et al., 2017). These
findings could be of relevance for designing efficient synthetic
glycoconjugate vaccines against S. pneumoniae.
In contrast to the above listed serotypes containing tetra-
to hexasaccharide units, the repeating unit of S. pneumoniae
serotype 3 CPS consists only of a disaccharide. Therefore, in
this case, besides the respective disaccharide and monosaccharide
units, one tetrasaccharide (comprising two repeating units)
and two different trisaccharides with shifted sequences were
synthesized and used in the microarray screening of two mAbs
raised against serotype 3 CPS (Parameswarappa et al., 2016).
FIGURE 5 | Selected examples of representative structures printed in bacterial carbohydrate microarrays. The repeating unit of Enterococcus faecalis LTA is shown
as representative of a glycerol phosphate LTA backbone. Bacterial β(1-2)-linked cyclic glucans can occur in unsubstituted form or substituted at Glc C6 with anionic
groups (e.g., succinyl in B. abortus). The structure shown for NTHi LOS corresponds to the major glycoform of strain 375. Because of space limitations, the structure
of the O-chain of K. pneumoniae LPS is shown below the structure of the LPS core. Unless specifically indicated, sugar units are D-stereoisomers in pyranoside
form. Sugars in furanoside form are labeled with the f suffix. GroA, glyceric acid; Gro, glycerol; GalA, galacturonic acid; P, phosphate; PEtN, phosphoethanolamine;
OAc, O-acetyl; PCho, phosphorylcholine.
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The results showed that the tetrasaccharide was bound better
than the smaller structures. Moreover, a tetrasaccharide-CRM197
conjugate was found to elicit opsonophagocytic antibodies in
mice and confer protection against serotype 3 in a model of
pneumococcal pneumonia (Parameswarappa et al., 2016), thus
validating the usefulness of the approach.
The CPS of carbapenem-resistant Klebsiella pneumoniae
has also been explored for their antigenic potential using a
similar strategy. A CRM197-conjugate of the hexasaccharide
repeating unit proved to be immunogenic in mice and rabbits,
and elicited antibodies able to promote phagocytosis of the
bacterium (Seeberger et al., 2017). CPSs have also been used
to develop vaccines against different invasive serogroups of
Neisseria meningitidis. However, in the case of meningococcal
serogroup B, vaccines based on non-capsular antigens are
needed because its capsule consists of autoantigenic α(2-8)-
linked polysialic acid. As an alternative, the antigenic potential of
the inner core structure of N. meningitidis LOS (Figure 5) was
examined (Reinhardt et al., 2015). A library of species-specific
mono- to tetrasaccharide structures was synthesized and used for
microarray-assisted screening of human sera. Strong IgG binding
to the tetrasaccharide GlcNAcα(1-2)Hepα(1-3)Hepα(1-5)Kdoα
(Hep denoting L-glycero-D-mannoheptose, and Kdo denoting
3-deoxy-D-manno-oct-2-ulosonic acid), which is the conserved
LPS inner core structure of all N. meningitidis immunotypes,
and to the related trisaccharide lacking Kdo was observed,
while binding to Hepα(1-3)Hepα(1-5)Kdoα was only weak,
revealing the importance of the distal GlcNAc for recognition.
Immunization of mice with a tetrasaccharide-CRM197 conjugate
elicited an antibody response against the tetrasaccharide. Of note,
mice serum antibodies bound to cells of a broad collection of
N. meningitidis strains, and the binding to a LPS-free mutant
was significantly lower, demonstrating the accessibility of the LPS
inner core on the cell surface. Interestingly, epitope mapping
using the microarray-printed library of synthetic structures
revealed that, unlike human serum antibodies, Kdo was the
immuno-dominant residue for the mice antibodies. A possible
explanation posed by the authors is the presence in mouse
germline antibodies of an inherited binding pocket specific for
Kdo. In that case, mice might not be the best model to evaluate
the synthetic Kdo-containing tetrasaccharide as potential vaccine
candidate. Moreover, it is likely that in this structure the Kdo
residue is much more exposed than in N. meningitidis cells, shed
membrane vesicles, or fragments from opsonized bacteria that
predictably elicited the antibodies detected in human serum.




Besides aiding in the identification of vaccine candidates,
bacterial glycan microarrays have helped to dissect the binding
specificities of mAbs obtained for diagnostic or therapeutic
purposes. An example is the antibody-based detection of
tuberculosis biomarkers, which can form the basis of an
inexpensive point-of-care diagnostic test. A suitable biomarker
is the Man-capped form of LAM that is found in the blood,
sputum, and urine of the patients. A high affinity recombinant
antibody found to interact only with array-printed synthetic
carbohydrates containing linear α(1-2)Man linkages, as present
in LAM caps, was shown to bind pathogenic mycobacterial
species and demonstrated improved sensitivity in the detection of
tuberculosis over standard diagnostic methodologies, particularly
when urine and serum clinical specimens were tested combinedly
(Chan et al., 2015).
On the other hand, immunotherapy using antibodies targeting
bacterial surface polysaccharides could be a valuable alternative
for fighting infections produced by antibiotic-resistant bacteria,
such as carbapenem-resistant K. pneumoniae. Two mAbs
displaying distinct binding patterns to a microarray containing
its CPS repeating unit and fragments thereof were found to
be protective against the most virulent clinical strains of this
bacterium, promoting their killing and preventing the spread
of infection in a murine model (Diago-Navarro et al., 2018).
Thus, they can be considered candidates for an antibody-based
approach to treat patients infected with carbapenem-resistant
K. pneumoniae, for which therapeutic options are scarce.
BACTERIAL GLYCAN ARRAYS FOR
IDENTIFICATION OF LIGANDS FOR
LECTINS OF THE INNATE IMMUNE
SYSTEM
While the antibody-mediated (acquired) immune response
requires time to develop after an antigenic challenge, the
innate immune response is immediate and it does not require
previous exposure to the pathogen, thus being the first
line of defense against infection. A variety of lectins that
recognize specific glycans on pathogens’ surfaces make an
important contribution to innate immune protection. The use
of microarrays incorporating bacterial glycan structures has
greatly facilitated the identification of ligands and dissection of
glycotopes recognized by these lectins (see Figure 6 for schematic
representation of lectins of the innate immune system cited
in this review).
The value of the approach was demonstrated in a study by
Palma et al. (2006) on the assignment of carbohydrate-binding
specificity for Dectin-1, the major receptor of the innate immune
system on leucocytes against fungal pathogens. The binding of
Dectin-1 to a microarray containing 187 neoglycolipids, prepared
by reductive amination from selected fractions of Saccharomyces
cerevisiae, Alcaligenes faecalis and Umbilicaria papulosa glucan
polysaccharides, and from other diverse glycans including many
mammalian type glycans, was examined. Remarkably, exclusive
binding of Dectin-1 to 10-mer or longer β(1-3)-linked gluco-
oligosaccharides, as present in A. faecalis glucan curdlan, was
detected. This strict requirement of long β(1-3)-linked chains
for binding was confirmed in a later study, in which a total of
153 gluco-oligosaccharide neoglycolipids from plant, fungal, and
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bacterial glucan polysaccharides were prepared by oxime-ligation
(Palma et al., 2015). In contrast, the innate immune receptor
DC-SIGN (dendritic cell-specific ICAM-3-grabbing nonintegrin)
exhibited a broad binding profile, which included recognition
of linear β(1-2)-gluco-oligosaccharides derived from the cyclic
β(1-2)-glucan of Brucella abortus (Palma et al., 2015). Using
a focused (1-2)-glucan array, binding of the closely related
endothelial cell receptor DC-SIGNR (also named L-SIGN) and
of serum mannose-binding protein to linear α and β(1-2)-gluco-
oligosaccharides was also observed, although showing distinct
lectin-specific binding patterns and differing influence of linkage
configuration and chain length (Zhang et al., 2016). Moreover,
DC-SIGN was found to recognize intact forms of cyclic B. abortus
β(1-2)-glucan (Figure 5) printed on microarrays using an
appropriate immobilization strategy (Table 2). Of note, linear
and circular β(1-2)-linked glucans are produced and secreted by
different Proteobacteria and are thought to be involved in biofilm
formation, interactions with the host, and modulation of immune
cells activities. Overall, these studies evidenced that although
these four C-type (Ca2+-dependent) lectins of the innate immune
system, i.e., Dectin-1, DC-SIGN, DC-SIGNR, and mannose-
binding protein, recognize glucans, their fine binding specificities
are noticeably different.
Analogous observations were made when the binding
patterns of several membrane C-type lectin receptors to an
array of mycobacterial glycans were compared. As mentioned
above, mycobacteria display unusual surface glycoconjugates. In
addition to AM and LAM, they comprise phosphatidyl-myo-
inositol mannosides, phenolic glycolipids, glycopeptidolipids,
trehalose mycolates, trehalose-containing LOSs, and capsular
α-glucans (Figure 1, right part). An array containing 60
chemically synthesized glycans, representing all these classes
of mycobacterial structures, was screened with a panel of
seven human C-type lectins as well as with bovine mincle
(Zheng R. B. et al., 2017), all of them found on the
surface of macrophages and/or dendritic cells. No ligands were
identified for the macrophage galactose receptor, consistent
with its specificity for GalNAc, which was absent from the
array. Appropriate ligands were neither present for blood
dendritic cell antigen 2 (BDCA-2). Although in this case
the primary binding site does bind Man, additional contacts
with a Gal residue at a secondary site are known to be
required for high-affinity binding. In contrast, DC-SIGN
strongly bound to LAM cap structures containing Man residues
without a clear preference for particular types of glycans,
and it was apparently able to bind internal Man residues.
Binding of DC-SIGN to several LAM core structures, possibly
inaccessible in the cell wall, and to a phosphatidyl-myo-inositol
derivative with terminal Manα(1-2)Man was also detected.
Interestingly, a different study revealed binding to array-printed
mycobacterial phosphatidylinositol mono- and di-mannosides
of the human soluble lectin ZG16p (Hanashima et al., 2015),
putting forward a possible involvement of this lectin in the
gastrointestinal immune system. The mannose receptor, present
on macrophages and sinusoidal endothelial cells, was found
to recognize several LAM cap and core structures (Zheng
R. B. et al., 2017). However, its binding pattern clearly
differed from that of DC-SIGN, as the presence of terminal
Man residues was a main factor for recognition. Indeed, the
mannose receptor bound to several glycans bearing a single
terminal Man, including a phenolic glycolipid. Three other
Man-specific lectins, DC-SIGNR, Dectin-2 (from macrophages
and dendritic cells), and langerin (present on Langerhans
cells), also showed preferential binding to ligands containing
exposed Man, although distinctive recognition patterns were
visible (Zheng R. B. et al., 2017). For example, langerin
bound ligands bearing single terminal Man residues, in
addition to more complex LAM structures, whereas Dectin-
2 and DC-SIGNR showed a more restricted binding profile,
with predominant recognition of Manα(1-2)Man-containing
structures. In striking contrast, bovine mincle, found in
macrophages and other antigen-presenting cells, bound to
a distinct set of mycobacterial glycans containing trehalose
(Glcα(1-1)αGlc), independently on variations in substituents,
including additions to the 4- or 6-hydroxyl groups of one
of the Glc residues. Thus, there was a clear non-overlap
between mycobacterial ligands for mincle and for the other
Man-specific receptors tested, which also showed distinctive
binding preferences.
In a different study, DC-SIGN was also found to interact
with the α(1-6)-mannan backbone of lipomannan, another
important glycolipid of the M. tuberculosis cell wall (Figure 1,
right part). Comparison of DC-SIGN binding to array-printed
mannans containing 7, 13, and 19 α(1-6)-linked Man units
revealed a clear preference for the longer chains (Leelayuwapan
et al., 2017), again indicating that this receptor is able to
bind internal Man residues. Moreover, binding of DC-SIGN
to other microbial glycans was recently observed using a
microarray containing 120 synthetic bacterial structures out
of over 300 structures (Geissner et al., 2019). In addition
to a M. tuberculosis AM hexasaccharide displaying terminal
Man, DC-SIGN was found to recognize N-acetyl-mannosamine
(ManNAc)-terminating oligosaccharides based on the CPS of
S. pneumoniae serotypes 4 and 9. Furthermore, binding to
several structures with terminal Hep, based on the LPS inner
core of H. influenzae, N. meningitidis, Proteus sp., and Yersinia
pestis, was also detected, with α(1-2)- (H. influenzae, Figure 5)
and α(1-3)- (N. meningitidis and Proteus) linked Hep being
more efficiently bound than α(1-7)-linked Hep (Y. pestis). These
results further highlighted the plasticity of DC-SIGN’s binding
site for accommodating Man-related structures, even bearing
substituents at positions 2 (as in ManNAc) or 6 (as in Hep),
thereby allowing this receptor to recognize a broad range of
microbial ligands.
The ability of human langerin to recognize bacterial
glycans different from those displayed by mycobacteria was
explored using a microarray containing a collection of 48
bacterial polysaccharides obtained by mild acid hydrolysis
of diverse LPSs (O-chain and core) (Feinberg et al., 2011).
Langerin bound to E. coli and Shigella boydii polysaccharides
containing Manα(1-2)Man units, indicating that this is an
important glycotope for langerin recognition. However,
binding to these structures was not detected in a later study
using an extended microarray, comprising over 300 bacterial
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FIGURE 6 | Lectins of the innate immune system examined using bacterial glycan microarrays. The lectins studied comprise several multimodular membrane
receptors that contain C-type carbohydrate-recognition domains (Solís et al., 2015) in addition to other non-lectin domains, specified in each case. The mannose
receptor also contains an R-type lectin domain. Soluble lectins examined also include two C-type lectins of the collectin family (so called because they contain a
collagenous region), which form different multimeric structures based on similar trimeric units. Other soluble lectins studied are different members of the galectin
family, belonging to the chimera type (containing one carbohydrate-recognition domain) and tandem-repeat type (containing two different carbohydrate-recognition
domains) structural subgroups, intelectin-1 (a member of the X-type lectin family), and a peptidoglycan recognition protein. MR, mannose receptor; BDCA-2, blood
dendritic cell antigen 2; DC-SIGN, dendritic cell-specific ICAM-3-grabbing nonintegrin; DC-SIGNR, endothelial cell DC-SIGN homolog; MGR, macrophage galactose
receptor; SP-D, surfactant protein D; MBP, serum mannose-binding protein; Gal-3/4/8/9, galectins 3/4/8/9; ITLN1, intelectin-1; PGRP-S, short peptidoglycan
recognition protein.
polysaccharides, intact LPSs, and CPSs from a broad range
of Gram-negative and -positive bacteria [microbial glycan
microarray of the Consortium for Functional Glycomics
(CFG)2]. Here, only weak binding signals were observed for
2http://www.functionalglycomics.org
some non-Man-containing Shigella and Yersinia antigens,
whereas robust binding to yeast mannan was found (Hanske
et al., 2017). Unfortunately, as none of these structures
were tested in the previous microarray, it is not possible to
compare the relative binding intensities obtained in these
two studies. Therefore, a further analysis of the binding
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of human langerin to the spotted E. coli, Shigella, and
Yersinia antigens is required. In contrast, despite exhibiting
structurally and thermodynamically identical binding to Man
and Manα(1-2)Man, murine langerin recognized a broad
set of oligosaccharides with highly heterogeneous structures,
what could be due to the presence in the murine form of a
secondary site, adjacent to the canonic binding site and able to
establish interactions with large glycans (Hanske et al., 2017).
This interspecies variability could be the result of distinct
evolutionary pressures imposed by the different expression
patterns of murine and human langerins and their exposure
to microbes.
The above-mentioned collections of 48 and 300 bacterial
glycans were also used to examine the binding of three
members of the galectin family belonging to two different
structural subgroups, i.e., galectin 3 (of chimera type), and
galectins 4 and 8 (of tandem-repeat-type) (Figure 6). Galectins
are a family of lectins widely expressed in epithelial and
immune cells and involved, among many other biological
phenomena, in inflammation and immunity. In the 48-glycan
array, a unique selectivity for the O antigen of Providencia
alcalifaciens O5 was observed. Importantly, binding of the
three galectins to the intact bacterium resulted in loss of
viability, demonstrating the utility of the microarray to unveil
host−bacteria interactions of functional significance (Stowell
et al., 2014). Further analysis of galectin binding to the
expanded set of 300 bacterial glycans revealed recognition of
a diversity of species presenting mammalian-like carbohydrate
determinants, as K. pneumoniae, E. coli, P. alcalifaciens, Proteus
vulgaris, and S. pneumoniae (Stowell et al., 2014). These
results demonstrated the ability of galectins to target bacteria
displaying self-like antigens. In striking contrast, intelectin-
1, a member of the X-type lectin family suspected to be
involved in innate immunity, bound in this extended array to
ligands containing β-linked galactofuranose, saccharide residues
with D-glycerol-1-phosphate substituents, Hep, D-glycero-D-
talo-oct-2-ulosonic acid, or Kdo residues, which are widely
distributed in bacteria but are not found in mammalian glycans
(Wesener et al., 2015). These two studies beautifully illustrate
the complementarity in the recognition of self-like and non-
self bacterial glycan epitopes by soluble lectins of the innate
immune system.
Besides, the binding of tandem-repeat type galectins
4, 8, and 9 to a different microarray incorporating a
collection of nearly 150 polysaccharides obtained by mild
acid degradation of LPSs from six different bacteria genera
(Escherichia, Shigella, Salmonella, Cronobacter, Proteus, and
Pseudomonas) was examined (Knirel et al., 2014). Although
galectins are characterized by a canonical β-galactoside-
binding ability, several β-galactoside-containing polysaccharides
with no forbidden substituents at the Gal moieties were not
recognized by these galectins. Moreover, binding to non-
βGal polysaccharides was detected. Keeping in mind that
natural polysaccharides are heterogeneous and may contain
minor populations that could account for the observed
behavior, this study put forward the binding of galectins to
non-canonical determinants.
Surfactant protein D (SP-D) is a different soluble lectin of the
innate immune system known to recognize LPSs of several Gram-
negative bacteria, triggering agglutination and phagocytosis. SP-
D belongs to the C-type collectin family and binds to the LPS
inner core Hep constituent. To get insights into the influence
of adjacent residues and Hep linkages, the binding of SP-D
to a glycan array containing 12 different synthetic inner core
structures was examined (Reinhardt et al., 2016). Preferred
binding to ligands containing tri-Hep terminal sequences over
shorter substructures was observed, the presence of an internal
Kdo having no detrimental effect on the recognition. However,
replacement of the external Hep moiety by GlcNAc resulted in
decreased binding. Moreover, a slight preference for terminal
α(1-2)- over α(1-7)-linked Hep was observed. Overall, the
results demonstrated SP-D binding to LPS inner core structures
present in, e.g., H. influenzae, Enterobacteriaceae, Proteus, or
N. meningitidis.
Other mammalian effectors of the immune system recognize
bacterial cell wall peptidoglycans and activate antimicrobial
defense systems, as, e.g., the so called peptidoglycan recognition
proteins (PGRPs). However, the recognized motifs are
poorly characterized. A series of peptidoglycan fragments
consisting of MurNAcβ(1-4)GlcNAc (MG, MurNAc standing
for N-acetylmuramic acid), (MurNAcβ(1-4)GlcNAc)2 (MGMG),
or (GlcNAcβ(1-4)MurNAc)2 (GMGM), conjugated to di- (L-
Ala-D-isoGln), tri- (L-Ala-D-isoGln-L-Lys), or tetrapeptides
(L-Ala-D-isoGln-L-Lys-D-Ala), were tested for the binding
of human PGRP-S (PGRP short, also known as PGRP 1)
(Wang et al., 2016). In accordance with previous data, PGRP-S
showed a preference for GMGM conjugates with tri- and
tetra-peptides over the dipeptide. In addition, PGRP-S was
also found to bind MGMG sequences, again with preference
for tri- and tetrapeptide-containing structures. Although
this could indicate that peptide length is important for
recognition, as interpreted by the authors, the possibility
that the Lys residue at position 3 of the tri-/tetra-peptides
could be specifically involved in the binding should not be
excluded.
In summary, a range of microarrays incorporating diverse
bacterial glycans, from large collections to more focused
libraries of a specific glycan type or bacterial origin (Table 2),
have been selectively used to investigate the binding behavior
of different lectins of the innate immune system, unveiling
a repertoire of complementary recognition profiles and
broad to very strict binding specificities, depending on the
particular lectin.
BACTERIAL GLYCAN ARRAYS FOR THE
STUDY OF LIGANDS RECOGNIZED BY
BACTERIAL AND PHAGIC GLYCAN
BINDING PROTEINS
Bacteria frequently use surface-exposed lectins to bind to host
glycans that serve as docking points for adhesion, and different
glycan microarray platforms mainly built with mammalian
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glycan libraries have been used to get insights into their mode
of binding and potential ligands (Flannery et al., 2015; Poole
et al., 2018) or to evaluate bacterial adhesion and the efficiency of
antiadhesive compounds (Kalograiaki et al., 2018a). In addition,
some of these lectins are involved in the formation of bacterial
microcolonies and biofilms through binding to glycans present
on the surface of neighbor cells or to secreted exopolysaccharides.
This is the case for several lectins from Pseudomonas aeruginosa
and Burkholderia cepacia species, two bacteria that can even
form mixed biofilms (Elias and Banin, 2012). The binding
specificity of P. aeruginosa lectins PA-IL and PA-IIL (also referred
to as LecA and LecB) and of B. cenocepacia lectins A and
C (designated BC2L-A and BC2L-C) was investigated using
glycan arrays from the Consortium for Functional Glycomics.
Despite PA-IIL and BC2L-A are closely related Man-binding
lectins, PA-IIL was found to show preference for fucosylated
oligosaccharides (Marotte et al., 2007), while BC2L-A only bound
to oligomannose glycans (Lameignere et al., 2008). Interestingly,
screening of the two separate carbohydrate-recognition domains
of BC2L-C revealed binding of the N-terminal domain to
fucosylated oligosaccharides and of the C-domain to Man-
terminated glycans (Sulak et al., 2011), thus combining in
one single lectin binding properties similar to those of PA-IIL
and BC2L-A. In contrast, PA-IL showed a high specificity for
terminal α-Gal, with preference for Galα(1-4)Gal-terminating
structures (Blanchard et al., 2008). Although the arrays tested
were based on mammalian glycan structures, binding of these
lectins to similar sugar epitopes in bacterial glycans, as, e.g.,
in the Gal- and Man-rich exopolysaccharide of P. aeruginosa
(Psl), could be extrapolated. In addition, PA-IIL, BC2L-A, and
BC2L-C could recognize Hep residues of LPSs, as described
above for the Man-specific innate immune lectins DC-SIGN
and SP-D. Indeed, binding of BC2L-A to Hep mono- and
disaccharides, and Hep-containing oligo- and polysaccharides
was later confirmed using a combination of NMR spectroscopy,
X-ray crystallography, and calorimetry techniques (Marchetti
et al., 2012). Moreover, binding of BC2L-A and the C-domain
of BC2L-C to microarray-printed Man or Hep terminating
bacterial glycans has very recently reported, this study unveiling
a preference of both lectins for α(1-6)- over α(1-2)-linked
Hep (Geissner et al., 2019). All in all, a study of the binding
patterns to appropriate bacterial glycan arrays would certainly
be of great help to identify the precise structures recognized by
the bacterial lectins. This in turn will facilitate the design of
new antibacterial agents able to interfere with microcolony and
biofilm formation.
Many bacterial glycoside hydrolases contain non-catalytic
CBMs that target the enzyme to specific regions on its
substrate and promote hydrolysis. A finely tuned selectivity
in carbohydrate recognition was demonstrated in a study
on the binding of six bacterial glucan-binding CBMs to the
collection of 153 gluco-oligosaccharide neoglycolipids described
in the preceding section (Palma et al., 2015). The analysis
confirmed known binding preferences, with distinct CBM-
specific profiles and differing influence of oligosaccharide
sequence and length, and also revealed novel binding specificities
including recognition of bacterial glycans. For example, CBM41
from Thermotoga maritima pullulanase showed the predicted
binding to α(1-4)-gluco-oligosaccharides, and the presence of
α(1-6)-linked Glc was found to be better tolerated at an internal
position than at the non-reducing end. Binding of CBM11 from
Clostridium thermocellum endoglucanase was in agreement with
its selectivity toward Glcβ(1-4)Glcβ(1-4)Glcβ(1-3)Glc, although
only heptasaccharide and longer chains were bound, suggesting
that chain length is important for recognition. In the case
of CBM4-2 from T. maritima laminarinase, which showed
preferential binding to linear β(1-3)-glucans, a minimum chain
length of four units was required, while for two CBMs from
Cellvibrio mixtus cellulase (CBM32-2) and Bacillus halodurans
laminarinase (CBM6), showing prominent binding to linear β(1-
2)- and β(1-3)-, as well as branched β(1-3/6)-oligosaccharides,
binding to di- and tri-saccharide structures could be detected.
Finally, CBM6-2 from C. mixtus endoglucanase 5A, which
contains two binding clefts with different specificity, exhibited
the broadest recognition profile, including binding to linear
β(1-2)-gluco-oligosaccharides derived from the cyclic β(1-2)-
glucan of B. abortus, not reported previously for this CBM.
This study demonstrated the effectiveness of the microarray
as a tool for probing recognition of short as well as long
bacterial glucans.
A different module present in bacterial peptidoglycan
hydrolases is the Lysin Motif (LysM) domain. This is a
widespread domain, found in proteins from viruses to mammals,
that recognizes polysaccharides containing GlcNAc residues,
as present in the bacterial cell wall peptidoglycan or in chitin,
the main constituent of fungal cell walls. Furthermore, plant
receptors containing LysM domains recognize lipochitin
oligosaccharides that are synthesized by nitrogen fixing bacteria
to be used as signaling molecules (Nod factors) in legume–
rhizobium symbiosis. A microarray containing a series of
natural and synthetic Nod factors, chitin oligosaccharides, and
peptidoglycan-related compounds was developed to investigate
interactions involving LysM domain-containing proteins
(Maolanon et al., 2014). Analysis of the binding to the array of
P60, an autolysin of Listeria monocytogenes that hydrolyzes the
cell wall peptidoglycan and is essential for bacterial virulence,
revealed recognition of chitin oligosaccharides of ≥ 5 GlcNAc
units and selective binding to some Nod factors, in particular
those containing a C18:1 lipid chain. Interestingly, a chemically
synthesized LysM domain of the Nod factor receptor 5 from
the legume Lotus japonicas was also found to show preference
for Nod factors with C18:1 lipid chains (Sorensen et al., 2014).
Thus, the bacterial and plant LysM domains appeared to
exhibit a similar dependence on the lipid structure, hinting
at a possible role of the lipid moiety in the binding of LysM
domains to Nod factors.
Bacteriophages also exploit recognition of specific bacterial
glycan motifs for invading their hosts. An example is the
lytic phage NCTC 12673, which recognizes the capsular
polysaccharide of only a limited number of C. jejuni isolates,
thereby conferring the phage its high host specificity. In
addition, NCTC 12673 contains a putative binding protein,
Gp047, with a much broader host-binding range than the
phage, being capable of binding to multiple C. jejuni and
Frontiers in Microbiology | www.frontiersin.org 18 January 2020 | Volume 10 | Article 2909
fmicb-10-02909 January 14, 2020 Time: 19:11 # 19
Campanero-Rhodes et al. Microarrays for Exploring Bacterial Glycans
Campylobacter coli strains. This protein was found to recognize
flagellin decorated with acetamidino-modified pseudaminic acid.
However, it did not bind any of the structures printed in
the 48-glycan array mentioned before, not even to glycans of
P. aeruginosa containing acetimidoyl groups, thus evidencing
the specific requirement for recognition of the acetamidino
modification on pseudaminic acid (Javed et al., 2015). The
authors proposed that Gp047 could be released from phage-
infected bacteria and bind to flagella of neighboring C. jejuni




GLYCANS AND THEIR RECOGNITION BY
GLYCAN-BINDING PROTEINS
The potential of microarrays incorporating natural or synthetic
bacterial glycan structures for exploring the recognition of
bacteria by carbohydrate-binding proteins is evidently limited
by the library of probes included in the array. If the particular
carbohydrate structure recognized by the protein is not present
in the array, the analysis may be misinterpreted as a lack of
binding to a given bacterium. On the other hand, the presentation
of the glycan probes in the array in an accessible and clustered
(high density) form may substantially differ from their natural
arrangement and accessibility on the bacterial surface. Therefore,
the possibility that the results do not correlate with the real
bacteria−receptor interplay does exist and poses a challenge to
the design of microarray-based strategies. Moreover, synergistic
operative interactions of the glycan-binding proteins with other
cell surface molecules cannot be evaluated. Therefore, besides
assessing recognition of isolated bacterial components by glycan-
binding proteins for identification of ligand candidates, analysis
of binding to bacterial supramolecular structures and entire
cells is needed.
An example is the study of the recognition of the
bacterial peptidoglycan by the cell wall-binding domain of the
endolysin Cpl-7, which is encoded by the pneumococcal Cp-
7 bacteriophage (Bustamante et al., 2017). Cpl-7 is composed
of a catalytic domain with muramidase activity and a cell
wall-binding domain (C-Cpl-7) made up of three CW_7
repeats. Although these repeats have only been characterized
in two other endolysins, they are present in many putative
cell wall hydrolase sequences, suggesting that they target a
conserved element of the bacterial cell wall. Inspection of the
mode of binding of peptidoglycan fragments to C-Cpl-7 using
a combination of X-ray crystallography, saturation transfer
difference NMR spectroscopy (STD-NMR), and docking studies,
unveiled GlcNAcβ(1-4)MurNAc-L-Ala-D-isoGln as the minimal
recognized fragment and the involvement, among other contacts,
of a fully conserved arginine residue in hydrogen bonding with
the GlcNAc moiety. Binding assays of C-Cpl-7 to cell wall
fragments from the laboratory S. pneumoniae strain R6, grown in
choline- or ethanolamine-containing media (i.e., with choline- or
ethanolamine-containing TAs), printed on nitrocellulose-coated
glass slides, confirmed recognition of the pneumococcal cell wall
independently of the choline or ethanolamine decoration of TAs
(Bustamante et al., 2017). Moreover, upon substitution in the
three repeats of the mentioned arginine residue by alanine, what
did not alter the protein structure, a decrease of around 50% in
the intensity of the binding signals was observed. These results
suggested that the mode of binding to the complex peptidoglycan
layer is likely to be analogous to that defined for the small
glycopeptide studied.
As endolysins break down the cell wall from the inside
of bacteria to release the phage progeny, the use of cell wall
fragments to investigate endolysins’ recognition of the bacterial
peptidoglycan (or of TAs) is indicated. However, the interaction
of glycan-binding proteins with bacterial surface glycans should
be better explored using microarray-printed entire cells. This
approach was used to detect antibodies against cell surface
antigens (Thirumalapura et al., 2006). Microarrays containing
inactivated E. coli, F. tularensis, K. pneumoniae, S. Typhimurium,
E. faecalis, S. aureus, S. epidermidis, Streptococcus pyogenes,
and L. monocytogenes cells were tested for the binding of
mAbs against F. tularensis O-antigen, Salmonella O-antigen (B
group), S. aureus peptidoglycan, and L. monocytogenes. Specific
recognition of the respective bacteria was demonstrated with
no meaningful cross-reactions. To assess the utility of the
approach for antibody detection in clinical samples, seven canine
serum samples from clinical cases of tularemia and positive for
F. tularensis antibodies, along with six canine serum samples
negative for F. tularensis antibodies, were comparatively tested.
Significantly higher levels of anti-F. tularensis antibodies were
detected in tularemia positive samples compared to negative
samples (Thirumalapura et al., 2006). In addition, variable levels
of antibodies against the other bacteria were also observed,
showing that simultaneous detection of different anti-bacteria
antibodies was possible.
More recently, bacteria microarrays have proved to be
useful for exploring the presence of carbohydrate structures on
bacterial surfaces (Campanero-Rhodes et al., 2015; Kalograiaki
et al., 2016, 2018b). K. pneumoniae O1:K2 strain 52145, a
clinically relevant serotype, was first used as model bacterium
(Campanero-Rhodes et al., 2015). This strain displays a Gal-
containing O-chain (Figure 5) and a CPS built by a branched
Glc/Man-based tetrasaccharide repeating unit, which are glycan
structures commonly found in isolates from K. pneumoniae-
infected individuals. By testing the binding of a panel of 10 lectins
of known binding specificities to array-printed K. pneumoniae
52145 cells, the accessibility for lectin recognition of Gal- and
Man/Glc-containing structures on the bacterial surface was
confirmed. A series of isogenic mutants lacking the capsule,
the LPS O-chain and/or the major outer membrane protein
OmpA, printed in parallel, helped to dissect the specific structures
recognized by those lectins giving meaningful binding signals
toward the wild type strain. A strong preference of the Gal-
specific lectins RCA and PNA (Table 3) for non-capsulated and
O-chain-containing strains was evident, pointing to the O-chain
as the primary recognized epitope. In the case of the Man/Glc-
specific lectin ConA, the results indicated that the CPS was not
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TABLE 3 | Binding specificities of model lectins mentioned in this review.
Lectin Abbreviation Source Monosaccharide Sugar-binding preferences
Concanavalin A ConA Canavalia ensiformis seeds Man/Glc α-Methyl-mannopyranoside > α-Man > α-Glc > α-GlcNAc
Wheat germ agglutinin WGA Triticum vulgaris GlcNAc [GlcNAc]3, [GlcNAc]2, GlcNAc. It may bind Neu5Ac, but not
Neu5Gc
Griffonia simplicifolia lectin II GSL-II Griffonia simplicifolia seeds GlcNAc Terminal α- or β-GlcNAc residues
Datura stramonium lectin DSL Datura stramonium seeds GlcNAc β(1-4)-linked GlcNAc oligomers:
Chitotriose > chitobiose > GlcNAc. Also LacNAc and LacNAc
oligomers





Ricinus communis seeds Gal Terminal β-Gal. Galβ(1-4)Glc >> Galβ(1-3)Glc. GalNAc is a very
poor inhibitor
Viscum album agglutinin VAA Viscum album leaves Gal Terminal β-Gal
Artocarpus integrifolia lectin Jacalin Artocarpus integrifolia seeds Gal Galβ(1-3)GalNAc (T-antigen), non-, mono- or di-sialylated
Erythrina cristagalli lectin ECL Erythrina cristagalli seeds Gal Lac, LacNAc
Soybean agglutinin SBA Glycine max seeds GalNAc/Gal Terminal α- or β-linked GalNAc and to a lesser extent Gal
residues
Helix pomatia agglutinin HPA Helix pomatia albumin gland GalNAc α-GalNAc over β-GalNAc. Weakly α-Gal
Aleuria aurantia lectin AAL Aleuria aurantia mushrooms Fuc Fuc α(1-6)-linked to GlcNAc or α(1-3)-linked to LacNAc related
structures
Maackia amurensis lectin I MAL-I Maackia amurensis seeds Gal Galβ(1-4)GlcNAc
Maackia amurensis lectin II MAL-II Maackia amurensis seeds Neu5Ac Neu5Acα(2-3)Galβ(1-3)GalNAc
Man, mannose; Glc, glucose; GlcNAc, N-acetylglucosamine; Gal, galactose; GalNAc, N-acetylgalactosamine; Fuc, fucose; Neu5Ac, N-acetylneuraminic acid; Neu5Gc,
N-glycolylneuraminic acid; LacNAc, N-acetyllactosamine; Lac, lactose.
the main recognized structure, as there was no preference for
capsulated over non-capsulated strains. Importantly, for all the
lectins the binding signals were reduced down to background
levels when the binding assays were carried out in the presence
of their specific haptens, thereby proving that lectin binding
was carbohydrate mediated. Therefore, other glycan structures
different from the CPS were apparently recognized by ConA.
The efficiency of bacteria microarrays for exploring the
presence of surface glycans of bacteria not presenting CPS and
O-antigen-containing LPS was next demonstrated using non-
typeable H. influenzae (NTHi) as model (Kalograiaki et al., 2016).
Binding assays to microarray-printed NTHi strain 375 (hereafter
referred to as NTHi375) with a panel of 19 lectins revealed
positive and hapten-inhibitable signals for Gal-, Glc-, and sialic
acid-specific lectins, indicating the presence on the bacterial
surface of carbohydrate structures specifically recognized by
the lectins. Analysis of lectin binding to a set of isogenic
mutant strains expressing sequentially truncated LOS supported
the notion that the LOS could be a target for most lectins.
Interestingly, LOS truncation had disparate consequences on the
binding of the Gal-specific lectins VAA and RCA (Table 3). In
particular, the absence of the Galα(1-4)Galβ epitope from the
chain extension linked to the distal manno-heptose of the Hep
trisaccharide inner core (Figure 5) resulted in decreased binding
of VAA but had no significant effect on the binding of RCA,
suggesting that RCA might not bind this LOS. Indeed, a follow
up study using microarrays containing the purified LOS showed
only marginal binding of RCA as opposed to strong binding of
VAA, which was drastically reduced for a truncated LOS lacking
Galα(1-4)Galβ (Kalograiaki et al., 2018c). In striking contrast,
RCA bound strongly to the microarray-printed LOS from
the capsule-deficient H. influenzae laboratory strain RdKW20,
whose major glycoform displays terminal Galβ(1-4)Glc at the
distal Hep extension, while, although ∼19% of this LOS bears
terminal Galα(1-4)Galβ, VAA bound only weakly. In-depth
analysis of the LOS epitopes recognized by RCA and VAA in
each case, using STD-NMR experiments assisted by molecular
dynamics simulations, revealed that RCA bound the RdKW20
LOS glycoform displaying terminal Galβ(1-4)Glcβ, whereas VAA
recognized the Galα(1-4)Galβ(1-4)Glcβ epitope (Figure 5) in
NTHi375 LOS but not in RdKW20 LOS, what could be due to
different conformational preferences of the branch and ensuing
presentation of the epitope. Binding assays to wild type and
selected mutant/transformed whole bacterial cells ran in parallel
revealed that, besides the LOS, other carbohydrate structures on
the bacterial surface serve as lectin ligands, and highlighted the
impact of the specific display of cell surface components on lectin
binding, stressing the importance of examining binding to entire
bacterial cells (Kalograiaki et al., 2018c).
Having proved the utility of bacteria microarrays for exploring
the presence of carbohydrate structures on the surface of
the model NTHi375 strain, the glycosignatures of five other
NTHi clinical isolates from otitis media and COPD (chronic
obstructive pulmonary disease) patients and from pediatric
healthy carriers were examined (Kalograiaki et al., 2016).
Different lectin-binding fingerprints were observed, consistent
with the known inter-strain heterogeneity of H. influenzae
LOS, which is linked to variable outcomes with the host,
i.e., colonization, persistence, or acute infection. Again, RCA
and VAA exhibited different binding patterns, supporting that
these two lectins recognize different ligands on the NTHi
surface. At any rate, the results evidenced the availability on
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the bacterial surface of Man/Glc, Gal, and sialic acid residues
that could be recognized by lectins of the innate immune
system with the appropriate carbohydrate-binding specificity.
Indeed, analysis of the binding of SP-D, galectin-8, and Siglec-14,
which exhibit Man/Glc, Gal, and sialic acid binding specificities,
respectively, to the array-printed NTHi clinical isolates revealed
lectin- and strain-specific recognition (Kalograiaki et al., 2016),
providing the first experimental evidence for direct binding of
SP-D to NTHi and also demonstrating binding of galectin-
8 and Siglec-14 to NTHi strains other than NTHi2019,
previously reported (Angata et al., 2013; Stowell et al.,
2014). Overall, the microarray analysis afforded information
on the glycosignatures of the tested bacteria and detected
recognition by host receptors, providing semiquantitative data on
binding avidity.
OTHER APPLICATIONS OF LECTIN,
ANTIBODY, AND BACTERIAL GLYCAN
MICROARRAYS
The main focus of this review was the description of microarray
strategies for exploring the presence of glycans on bacterial
surfaces and their interactions with a diversity of glycan-binding
proteins. Still, other interesting microarray approaches that
could be of value to the microbiologist community deserve
to be mentioned.
A first example is the use of a sandwiched microarray platform
for testing the efficiency of antibiotics on S. aureus growth (Liu
et al., 2016). A lectin-hydrogel microarray was employed for
capturing bacteria, and a matching drug-laden polyacrylamide
microarray was then used for building microchambers between
the two microarrays, in which live bacteria were co-cultured
with antibiotics. Minimum inhibitory concentrations obtained in
this way for four well-known antibiotics were in agreement with
reported values.
Antibody microarrays have been used for detecting bacteria in
a diversity of samples, covering from water to rocks. For example,
E. coli O157:H7, S. Typhimurium, and Legionella pneumophila,
which are responsible for water-borne infections, were detected
in water using a flow-through chemiluminescence microarray
approach (Wolter et al., 2008; Karsunke et al., 2009). A method
for fast detection of clinically relevant levels of S. Enteritidis in
blood, based on monitoring of bacterial growth by SPRi, has also
been reported (Templier et al., 2017). The method was claimed
to be of value for detecting bloodstream bacterial infections
(bacteremia) using blood volumes similar to those used in
standard analyses. Moreover, microarrays containing collections
of up to 300 antibodies have been used for environmental
monitoring of bacteria, in, e.g., aquatic ecosystems (Blanco et al.,
2015), or even detection of “signs of life” in solid samples,
including sediments, rocks, and subsoil samples, especially those
from extreme environments such as the hypersaline Atacama
subsurface (Parro et al., 2011) or the permafrost from the
antarctical Deception Island (Blanco et al., 2012). Although
most of the antibodies used in these studies did not explicitly
target bacterial glycan structures, as they were raised against
whole bacterial cells, in some cases detection of bacterial
exopolysaccharides, LTAs, and peptidoglycans was demonstrated
(Rivas et al., 2008; Parro et al., 2011; Blanco et al., 2012; Puente-
Sánchez et al., 2014). Of note, the successful results obtained with
these arrays supported their utility for planetary exploration, as,
e.g., the search for life in Mars.
Regarding carbohydrate microarrays, a singular approach
involving binding assays of purified bacterial glycans to
microarray-printed host glycans was used to examine host–
bacteria glycan–glycan interactions. Numerous interactions of
LOS/LPSs isolated from C. jejuni, H. influenzae, S. Typhimurium,
and Shigella flexneri with the printed probes were detected (Day
et al., 2015). Moreover, cell assays demonstrated that adherence
of bacteria to host cells could be inhibited with either host or
bacterial glycans, indicating that the observed glycan−glycan
interactions could importantly contribute to the binding of
bacteria to host cells. As mentioned before, the potential of
carbohydrate microarrays for exploring recognition events is
limited by the library of probes used for building the arrays,
what is frequently restricted by the laborious procedures required
for obtaining well-defined glycan structures. Engineered phages
displaying specific oligosaccharides, named “glycophages,” have
been put forward as an alternative (or complement) to the
commonly used glycan libraries of natural and/or synthetic origin
(Çelik et al., 2015). In particular, microarray-printed phages
displaying the P. aeruginosa O11 O-antigen were successfully
recognized by serum antibodies against this O-antigen, which did
not bind to other glycophages in the array displaying O-antigen
polysaccharides from C. jejuni, Campylobacter lari, E. coli O78,
E. coli O148, F. tularensis, or Shigella dysenteriae, demonstrating
the applicability of the approach. A key advantage of glycophages
is that they can be produced in bacteria in large quantities and
isolated easily from bacterial supernatants.
CONCLUDING REMARKS
As illustrated in this review, the number and diversity of
applications of the microarray technology grow continuously,
offering novel and complementary high-throughput tools for
bacteria-related studies in multiple areas, from basic science
to the clinical or food safety fields and even environmental
exploration. Still, several advances are required to maximize
the potential of this technology. For example, the binding
specificity of microarray-printed lectins has been typically
investigated using eukaryotic glycans as ligand candidates.
Therefore, their ability to recognize sugar residues and structures
exclusively found in bacteria is not known in most cases and
should be thoroughly examined. Production of recombinant
lectins with engineered binding specificities would definitely
facilitate a wider and more selective coverage of bacterial
glycans. Regarding antibody microarrays, the quality and cross-
reactivity of anti-carbohydrate antibodies are important issues
to tackle. In addition, increased sensitivity is required to
enable their use as routine tool for detection of contaminating
bacteria in real-world samples. Expansion of bacterial glycan
libraries through improved methods for isolation and structural
characterization or chemical/enzymatic synthesis or by exploiting
novel alternatives, as the above-mentioned “glycophages,” would
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enhance the potential of carbohydrate microarrays for exploring
recognition events. Common to all types of microarrays is
the need of better tools to analyze data and to establish
functional correlations, e.g., between bacterial glycosignatures
and virulence. These and other developments leading to a greater
simplicity and accessibility to this technique will surely broaden
its applications in bacterial glycobiology and related areas.
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